Yomi Pharma is a young biotech company exploiting the natural properties of sortilin protein to develop innovative therapeutic solutions. Our ambition is to develop and clinically validate therapeutic assets, particularly in oncology. Our first candidate is a peptide derived from sortilin that targets lung adenocarcinoma.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Ester Technopole, 1 Avenue D'ester,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- oncology and therapies.
- HQ
- Limoges, Nouvelle-Aquitaine
Yomi Pharma Questions
Yomi Pharma's LinkedIn profile is https://fr.linkedin.com/company/yomi-pharma
Yomi Pharma has
4 employees.
View email and phone details for 4
employees at Yomi Pharma.
Yomi Pharma's industry is
Biotechnology Research
Yomi Pharma's top competitors are
Serendip Innovations,
Meccellis Biotech,
Recobia Therapeutics,
Orinova,
See2cure,
Stimunity,
Moovand,
React Therapeutics,
Cytea Bio,
Capital Cell.
Yomi Pharma's categories are Biotechnology Research
Yomi Pharma's founding year is 2023
